Powered by

Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting

Nov 29, 2018 - GlobeNewswire

BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today announced that it will present the long-term analyses of the NEURO-TTR open-label extension study and TEGSEDI's impact on the lives of patients living with polyneuropathy caused by hereditary transthyretin amyloidosis (hATTR) at the 60th American Society of Hematology Annual Meeting and Exposition in San Diego, California, December 1-4, 2018.

In addition ...